Device
Laser Speckle Imaging
Laser Speckle Imaging is a medical device with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
2
50%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(2)
Terminated(1)
Detailed Status
Completed2
Withdrawn1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
withdrawn125%
recruiting125%
completed250%
Recent Activity
1 active trials
Showing 4 of 4
completednot_applicable
Post-occlusive Reactive Hyperemia and Basal-cell Carcinoma
NCT01455363
recruitingnot_applicable
Laser Speckle Imaging During Breast Reconstruction
NCT06523452
completed
Noninvasive Optical Measurement of Critical Care Neonates
NCT01483703
withdrawn
A Pilot Study Using Laser Speckle Imaging of Neonate Cerebral Vasculature
NCT01166880
Clinical Trials (4)
Showing 4 of 4 trials
NCT01455363Not Applicable
Post-occlusive Reactive Hyperemia and Basal-cell Carcinoma
NCT06523452Not Applicable
Laser Speckle Imaging During Breast Reconstruction
NCT01483703
Noninvasive Optical Measurement of Critical Care Neonates
NCT01166880
A Pilot Study Using Laser Speckle Imaging of Neonate Cerebral Vasculature
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4